Early research (Phase 1)Ended earlyNCT04261439
What this trial is testing
A Phase I/Ib Study of NIZ985 Alone and in Combination With Spartalizumab
Who this might be right for
In Escalation: All Patients With Solid Tumors and LymphomaIn Expansion: Melanoma, Non-small Cell Lung Cancer
Novartis Pharmaceuticals 60